Skip to main content
Clinical Trials/NCT03893292
NCT03893292
Withdrawn
Not Applicable

A Pilot Study on the Utility of Cooled Radiofrequency Ablation in Patients Prior to Total Knee Arthroplasty

Hospital for Special Surgery, New York1 site in 1 countryJanuary 24, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
Hospital for Special Surgery, New York
Locations
1
Primary Endpoint
Pain
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

Total knee replacement surgery is commonly performed for patients suffering from severe knee osteoarthritis. However, 20% of patients continue to experience pain after surgery. There is currently no standardized pain management protocol for pain after total knee replacement. Cooled radiofrequency ablation has been used successfully to alleviate spin-related pain and has recently been approved by the FDA to treat chronic knee arthritic pain. This pilot study aims to collect preliminary data on the use of cooled radiofrequency ablation in patients undergoing total knee replacement.

Detailed Description

The number of patients who undergo total knee replacement is rising significantly. However, many of these patients are dissatisfied with the results, because they continue to experience pain postoperatively. This pain can be debilitating and can also be associated with decreased quality of life. Given the increasing number of patients undergoing total knee replacement and a dissatisfaction rate of 8-44%, improvements must be made in pain management protocols to help decrease pain in the immediate postoperative period following total knee replacement. Cooled radiofrequency ablation is a procedure that uses water-cooled technology to denervate the sensory nerves. It is widely used in the spine and is increasingly being used in the knee to treat osteoarthritis. Existing studies have shown that it can significantly reduce pain in patients with chronic osteoarthritis. In terms of its potential benefit as a preoperative measure to minimize postoperative pain, the literature is sparse. Results from this study will be used to generate hypotheses and power for future studies.

Registry
clinicaltrials.gov
Start Date
January 24, 2019
End Date
October 30, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital for Special Surgery, New York
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing unilateral primary total knee replacement for osteoarthritis
  • Pain \>6 (on a scale of 0-10)
  • Body mass index: 21-35 kg/m2

Exclusion Criteria

  • Age \<65 years
  • Patients who are wheelchair bound
  • History of inflammatory arthritis or rheumatic disease
  • Body mass index \<21 or \>35 kg/m2
  • Chronic opioid use
  • Pregnant women
  • Non-English speaking

Outcomes

Primary Outcomes

Pain

Time Frame: Up to 1 year post-total knee replacement

Pain will be assessing on a 0-10 scale, where 0=no pain and 10=most pain.

Secondary Outcomes

  • Knee Disability(Up to 1 year post-total knee replacement)
  • Function assessed using the PROMIS-physical function computer adaptive test(Up to 1 year post-total knee replacement)

Study Sites (1)

Loading locations...

Similar Trials